Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model
about
NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancerMolecular imaging of brain localization of liposomes in mice using MALDI mass spectrometry.Contribution of protease-activated receptor 1 in status epilepticus-induced epileptogenesis.Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain.Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.Isolated brain metastasis as a late recurrence of completely resected non-small cell lung cancer.Rapid and reversible enhancement of blood-brain barrier permeability using lysophosphatidic acid.Modulation of blood-brain barrier permeability in mice using synthetic E-cadherin peptideWhich drug or drug delivery system can change clinical practice for brain tumor therapy?Chlorotoxin: Structure, activity, and potential uses in cancer therapy.Embracing rejection: Immunologic trends in brain metastasis.Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood-brain barrier.Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma.Salicylic acid analogues as chemical exchange saturation transfer MRI contrast agents for the assessment of brain perfusion territory and blood-brain barrier opening after intra-arterial infusion.Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.Early detection of human glioma sphere xenografts in mouse brain using diffusion MRI at 14.1 T.
P2860
Q35805489-ECCB9DA6-0A29-4794-BDF0-B36663C56391Q36138874-72475BEC-6E42-4F8E-9192-BB8A135CA428Q36380440-13DAC643-56A5-4629-A26D-B295830B9BF8Q36587860-018A04ED-D1BF-4AB8-92A8-2C09464CE70DQ36600202-2E3C8F8A-0D68-449A-BFF8-2B059831B380Q37002744-17F60394-55AC-43C2-A704-25A22BEA83CAQ37365650-7E2A666C-B6DA-4CFB-A3BE-D16972F2A443Q37714242-616E3208-409C-458C-80EF-D8E7123D08ADQ38090394-C135D364-4109-4F6A-85FA-30899181FF4AQ38595154-7A769EAC-7932-41A8-BB9C-DB1CBBF203ADQ38953017-D85130EE-F25C-499F-9A7A-40D5480AE672Q38975707-24F4A125-8D7C-4272-8A67-751B8180A024Q39029184-AD621520-3F75-43EF-90CD-6444422839BBQ42011053-77234011-8081-4DB2-B03C-1FECE9290DC5Q45864012-8AA2D52F-B362-424A-98BF-6FE06DA97082Q48475059-1B1BD9C3-62CE-4B7C-8E0D-A5364B11130E
P2860
Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model
@ast
Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model
@en
type
label
Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model
@ast
Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model
@en
prefLabel
Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model
@ast
Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model
@en
P2093
P2860
P1476
Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model
@en
P2093
Corbin J Bachmeier
Donald W Miller
Grant M Hatch
Ryan Mitchell
Sanjot D Savant
P2860
P2888
P304
P356
10.1007/S11060-012-1006-1
P577
2012-11-27T00:00:00Z